Cargando…
Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro?
Knee septic arthritis is a devastating complication following anterior cruciate ligament (ACL) reconstruction. To prevent this issue, intraoperative soaking of ACL grafts with vancomycin is often performed before implantation. Although vancomycin cytotoxicity has been reported several times, little...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466500/ https://www.ncbi.nlm.nih.gov/pubmed/34572669 http://dx.doi.org/10.3390/antibiotics10091087 |
_version_ | 1784573155358015488 |
---|---|
author | Papalia, Rocco Cicione, Claudia Russo, Fabrizio Ambrosio, Luca Di Giacomo, Giuseppina Vadalà, Gianluca Denaro, Vincenzo |
author_facet | Papalia, Rocco Cicione, Claudia Russo, Fabrizio Ambrosio, Luca Di Giacomo, Giuseppina Vadalà, Gianluca Denaro, Vincenzo |
author_sort | Papalia, Rocco |
collection | PubMed |
description | Knee septic arthritis is a devastating complication following anterior cruciate ligament (ACL) reconstruction. To prevent this issue, intraoperative soaking of ACL grafts with vancomycin is often performed before implantation. Although vancomycin cytotoxicity has been reported several times, little is known about its biological effect on tenocytes. The aim of this study was to evaluate the in vitro effects of vancomycin on human primary tenocytes (hTCs). hTCs were isolated from hamstring grafts of four patients undergoing ACL reconstruction. After expansion, hTCs were treated with different concentrations of vancomycin (0, 2.5, 5, 10, 25, 50 and 100 mg/mL) for 10, 15, 30 and 60 min. In vitro cytotoxicity was evaluated measuring metabolic activity, cell toxicity, and apoptosis. hTC metabolic activity was affected starting from 10 mg/mL vancomycin and decreased markedly at 100 mg/mL. Cell viability remained unaffected only at a concentration of 2.5 mg/mL vancomycin. Vancomycin cytotoxicity was detected from 10 mg/mL after 15 min and at all higher concentrations. Cells died when treated with concentrations higher than 5 mg/mL. The use of this antibiotic on tendons to prevent infections could be useful and safe for resident cells if used at a concentration of 2.5 mg/mL for up to 1 h of treatment. |
format | Online Article Text |
id | pubmed-8466500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84665002021-09-27 Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? Papalia, Rocco Cicione, Claudia Russo, Fabrizio Ambrosio, Luca Di Giacomo, Giuseppina Vadalà, Gianluca Denaro, Vincenzo Antibiotics (Basel) Article Knee septic arthritis is a devastating complication following anterior cruciate ligament (ACL) reconstruction. To prevent this issue, intraoperative soaking of ACL grafts with vancomycin is often performed before implantation. Although vancomycin cytotoxicity has been reported several times, little is known about its biological effect on tenocytes. The aim of this study was to evaluate the in vitro effects of vancomycin on human primary tenocytes (hTCs). hTCs were isolated from hamstring grafts of four patients undergoing ACL reconstruction. After expansion, hTCs were treated with different concentrations of vancomycin (0, 2.5, 5, 10, 25, 50 and 100 mg/mL) for 10, 15, 30 and 60 min. In vitro cytotoxicity was evaluated measuring metabolic activity, cell toxicity, and apoptosis. hTC metabolic activity was affected starting from 10 mg/mL vancomycin and decreased markedly at 100 mg/mL. Cell viability remained unaffected only at a concentration of 2.5 mg/mL vancomycin. Vancomycin cytotoxicity was detected from 10 mg/mL after 15 min and at all higher concentrations. Cells died when treated with concentrations higher than 5 mg/mL. The use of this antibiotic on tendons to prevent infections could be useful and safe for resident cells if used at a concentration of 2.5 mg/mL for up to 1 h of treatment. MDPI 2021-09-08 /pmc/articles/PMC8466500/ /pubmed/34572669 http://dx.doi.org/10.3390/antibiotics10091087 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Papalia, Rocco Cicione, Claudia Russo, Fabrizio Ambrosio, Luca Di Giacomo, Giuseppina Vadalà, Gianluca Denaro, Vincenzo Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? |
title | Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? |
title_full | Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? |
title_fullStr | Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? |
title_full_unstemmed | Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? |
title_short | Does Vancomycin Wrapping in Anterior Cruciate Ligament Reconstruction Affect Tenocyte Activity In Vitro? |
title_sort | does vancomycin wrapping in anterior cruciate ligament reconstruction affect tenocyte activity in vitro? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466500/ https://www.ncbi.nlm.nih.gov/pubmed/34572669 http://dx.doi.org/10.3390/antibiotics10091087 |
work_keys_str_mv | AT papaliarocco doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro AT cicioneclaudia doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro AT russofabrizio doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro AT ambrosioluca doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro AT digiacomogiuseppina doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro AT vadalagianluca doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro AT denarovincenzo doesvancomycinwrappinginanteriorcruciateligamentreconstructionaffecttenocyteactivityinvitro |